Impact of timing of adjuvant chemotherapy for early breast cancer: the Royal Marsden Hospital experience

BACKGROUND: The optimal time to deliver adjuvant chemotherapy has not been defined. METHODS: A retrospective study of consecutive patients receiving adjuvant anthracycline and/or taxane 1993–2010. Primary endpoint included 5-year disease-free survival (DFS) in patients commencing chemotherapy <31...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Br J Cancer
Main Authors: Okines, Alicia F. C., Kipps, Emma, Irfan, Tazia, Coakley, Maria, Angelis, Vaselios, Asare, Bernice, Mohammed, Kabir, Walsh, Geraldine, Ring, Alistair, Johnston, Stephen R. D., Parton, Marina, Turner, Nicholas C., Smith, Ian E.
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8292350/
https://ncbi.nlm.nih.gov/pubmed/34017085
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-021-01428-4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados